scispace - formally typeset
A

Anthony R. Fooks

Researcher at Animal and Plant Health Agency

Publications -  37
Citations -  777

Anthony R. Fooks is an academic researcher from Animal and Plant Health Agency. The author has contributed to research in topics: Rabies & Rabies virus. The author has an hindex of 14, co-authored 37 publications receiving 505 citations. Previous affiliations of Anthony R. Fooks include St George's Hospital & Veterinary Laboratories Agency.

Papers
More filters
Journal ArticleDOI

Assessing the risks of SARS-CoV-2 in wildlife

TL;DR: Surveillance efforts should be integrated with information from public and veterinary health initiatives to provide insights into the potential role of wild mammals in the epidemiology of SARS-CoV-2, and a framework for collating and synthesising emerging information is described.
Journal ArticleDOI

Monoclonal antibodies for prophylactic and therapeutic use against viral infections

TL;DR: Progress in developing inexpensive production platforms will make antiviral mAbs more widely available and affordable, and this work will help to overcome issues of neutralization escape.
Journal ArticleDOI

Isolation of a European bat lyssavirus type 2 from a Daubenton's bat in the United Kingdom

TL;DR: The isolation of EBLV-2 from a bat found on the west coast of England provides evidence that this virus may be present within the UK Daubenton's bat population at a low prevalence level.
Posted ContentDOI

Assessing the Risks of SARS-CoV-2 in Wildlife

TL;DR: Dynamic risk assessment and targeted surveillance are important tools for the early detection of infection in wildlife, and a framework for collating and synthesising emerging information to inform targeted surveillance for SARS-CoV-2 in wildlife is described.
Journal ArticleDOI

Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans

TL;DR: The results provide the molecular rationale for developing 62‐71‐3 mAb for rabies PEP and establish the basis for developing an inexpensive plant‐based antibody product to benefit low‐income families in developing countries.